Feasibility of Cervical Cancer Screening Policy Using Self-Collected Samples for HPV DNA Testing in Thailand

Author(s)

Kositamongkol C1, Mepramoon E2, Kanchanasurakit S3, Talungchit P4, Chaopotong P4, Kengkla K5, Chaisathaphol T2, Saokaew S5, Phisalprapa P2
1Division of Ambulatory Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10, Thailand, 2Division of Ambulatory Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok Noi, Bangkok, Thailand, 3Phrae Hospital, Muang Phrae, Phrae, Thailand, 4Department of Obstetrics and Gynecology, Mahidol University, Bangkok Noi, Bangkok, Thailand, 5University of Phayao, Mueang Phayao, Phayao, Thailand

OBJECTIVES: Although all Thai women are entitled to access cervical cancer screening services, the incidence and mortality rates of the cancer are still high. Several factors, such as knowledge, embarrassment, and inconvenience, affect the screening rate and hinder the success of the screening policy. Recently, self-collected samples for HPV DNA testing have been included in the health benefit coverage for Thai women. This should decrease screening-related barriers. Therefore, our study aimed to assess the feasibility of cervical cancer screening policy by using self-collected samples for HPV DNA testing in Thailand.

METHODS: Intensive individual in-depth interviews were carried out in 40 participants to explore their perspectives. Participants included medical providers involved in cervical cancer screening (n=20) and women aged 25-65 years who were the target group of the screening (n=20). This study was conducted at Siriraj Hospital. There were 2 separated listed of open-ended questions for providers and target group.

RESULTS: Most participants thought that a self-collected samples for HPV DNA testing was acceptable, and considered it as a promising way to decrease the barriers to screening uptake. However, some concerns were raised. Samples might not be collected and delivered accurately. Injury might occur during the self-sampling procedure. Public relations and education for patients and providers are important parts of the policy success. All pointed out that women who were at risk or had gynecological symptoms had to be examined by a clinician. Moreover, a consensus clinical practice protocol for cervical cancer screening is needed.

CONCLUSIONS: A self-collected samples for HPV DNA testing was highly accepted and supported by both providers and the target group. To maximize the screening rate, providing awareness about the importance of screening is key. Nevertheless, this screening method cannot replace a clinician screening, it should be considered as another option to increase the screening rate in non-attendees.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

HTA176

Topic

Health Technology Assessment, Patient-Centered Research

Topic Subcategory

Decision & Deliberative Processes, Stated Preference & Patient Satisfaction

Disease

Oncology, Reproductive & Sexual Health

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×